Correlation Between Hillstream Biopharma and Accustem Sciences

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Hillstream Biopharma and Accustem Sciences at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Hillstream Biopharma and Accustem Sciences into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Hillstream Biopharma and Accustem Sciences, you can compare the effects of market volatilities on Hillstream Biopharma and Accustem Sciences and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Hillstream Biopharma with a short position of Accustem Sciences. Check out your portfolio center. Please also check ongoing floating volatility patterns of Hillstream Biopharma and Accustem Sciences.

Diversification Opportunities for Hillstream Biopharma and Accustem Sciences

0.17
  Correlation Coefficient

Average diversification

The 3 months correlation between Hillstream and Accustem is 0.17. Overlapping area represents the amount of risk that can be diversified away by holding Hillstream Biopharma and Accustem Sciences in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Accustem Sciences and Hillstream Biopharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Hillstream Biopharma are associated (or correlated) with Accustem Sciences. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Accustem Sciences has no effect on the direction of Hillstream Biopharma i.e., Hillstream Biopharma and Accustem Sciences go up and down completely randomly.

Pair Corralation between Hillstream Biopharma and Accustem Sciences

Given the investment horizon of 90 days Hillstream Biopharma is expected to under-perform the Accustem Sciences. But the stock apears to be less risky and, when comparing its historical volatility, Hillstream Biopharma is 1.21 times less risky than Accustem Sciences. The stock trades about -0.03 of its potential returns per unit of risk. The Accustem Sciences is currently generating about 0.04 of returns per unit of risk over similar time horizon. If you would invest  105.00  in Accustem Sciences on August 27, 2024 and sell it today you would lose (72.00) from holding Accustem Sciences or give up 68.57% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthInsignificant
Accuracy25.49%
ValuesDaily Returns

Hillstream Biopharma  vs.  Accustem Sciences

 Performance 
       Timeline  
Hillstream Biopharma 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Hillstream Biopharma has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of comparatively stable essential indicators, Hillstream Biopharma is not utilizing all of its potentials. The current stock price uproar, may contribute to short-horizon losses for the private investors.
Accustem Sciences 

Risk-Adjusted Performance

2 of 100

 
Weak
 
Strong
Weak
Compared to the overall equity markets, risk-adjusted returns on investments in Accustem Sciences are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively fragile basic indicators, Accustem Sciences unveiled solid returns over the last few months and may actually be approaching a breakup point.

Hillstream Biopharma and Accustem Sciences Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Hillstream Biopharma and Accustem Sciences

The main advantage of trading using opposite Hillstream Biopharma and Accustem Sciences positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Hillstream Biopharma position performs unexpectedly, Accustem Sciences can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Accustem Sciences will offset losses from the drop in Accustem Sciences' long position.
The idea behind Hillstream Biopharma and Accustem Sciences pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Pattern Recognition module to use different Pattern Recognition models to time the market across multiple global exchanges.

Other Complementary Tools

Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account
Funds Screener
Find actively-traded funds from around the world traded on over 30 global exchanges
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Top Crypto Exchanges
Search and analyze digital assets across top global cryptocurrency exchanges